Author(s): Binder DC, Fu YX, Weichselbaum RR
Abstract Share this page
Abstract Combining radiation and immune checkpoint blockade provides synergistic antitumor responses in animal models and a small subset of patients. New preclinical data have provided mechanistic insight into this treatment interaction and identification of therapeutic targets to optimize this approach. Copyright © 2015 Elsevier Ltd. All rights reserved.
This article was published in Trends Mol Med
and referenced in Immunotherapy: Open Access